Viewing Study NCT03617666


Ignite Creation Date: 2025-12-24 @ 4:15 PM
Ignite Modification Date: 2025-12-28 @ 2:43 PM
Study NCT ID: NCT03617666
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2023-12-12
First Post: 2018-07-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Avelumab in the Frontline Treatment of Advanced Classical Hodgkin Lymphoma - a Window Study
Sponsor: University College, London
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2019-09-27
Start Date Type: ACTUAL
Primary Completion Date: 2022-07-04
Primary Completion Date Type: ACTUAL
Completion Date: 2025-05-30
Completion Date Type: ESTIMATED
First Submit Date: 2018-07-20
First Submit QC Date: None
Study First Post Date: 2018-08-06
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-12-05
Last Update Post Date: 2023-12-12
Last Update Post Date Type: ACTUAL